Lucid Ultra 128 vs MDHearing Volt

The Lucid Ultra 128 is a premium behind-the-ear prescription hearing aid priced at $5,000, earning an A grade with a SoundScore of 4.4/5 in our lab testing. It ranks #17 among 39 prescription hearing aids tested, placing it in the top 41% of its category. Speech performance is where the Lucid Ultra 128 truly excels. In our lab testing, speech in quiet scored a strong 4.3/5, which is 0.95 points above the category average. Speech in noise performance reached 2.7/5, which sits above the category average by 0.59 points, though it remains mixed in absolute terms. This suggests the device handles conversational clarity well in our test scenarios, particularly in quieter environments. The device does face some challenges. Feedback handling scored just 1.7/5, falling 3.02 points below the category average of 4.72/5—a notable weakness compared to other prescription aids in our testing. Music streaming also came in below average at 2.3/5, which is 0.46 points under the category norm. Own-voice comfort scored a mixed 2.9/5, slightly above average. At this price point, several competitors in our database achieved higher overall scores, including the Phonak Sphere Infinio and Oticon Intent. The Lucid Ultra 128 features disposable batteries and supports both iPhone and Android streaming. It may appeal to users who prioritize speech clarity in quiet settings and are less concerned about feedback stability or music streaming fidelity in our standardized tests.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.